Literature DB >> 31997264

Protective effects of losartan on some type 2 diabetes mellitus-induced complications in Wistar and spontaneously hypertensive rats.

Daniela Pechlivanova1, Ekaterina Krumova2, Nedelina Kostadinova2, Jeny Mitreva-Staleva2, Petar Grozdanov2, Alexander Stoynev3.   

Abstract

Diabetes mellitus type 2 (T2DM) is characterized by resistance of insulin receptors and/or inadequate insulin secretion resulting in metabolic and structural complications including vascular diseases, arterial hypertension and different behavioral alterations. We aimed to study the effects of the antihypertensive angiotensin AT1 receptor antagonist losartan on the T2DM-induced changes of exploratory behavior, anxiety, nociception and short term memory in normotensive Wistar and spontaneously hypertensive rats (SHRs). The experimental model of T2DM induced by a combination of high fat diet and streptozotocin, decreased exploratory activity and increased the level of carbonylated proteins in selected brain structures in both strains; as well it increased corticosterone level, pain threshold, anxiety-like behavior, and decline short term memory only in SHRs. Losartan treatment alleviated some of the T2DM- induced metabolic complications, abolished the T2DM-induced hypo activity, and normalized the corticosterone level, carbonylated proteins in brain, nociception and memory. Losartan did not exert effect on the anxiety behavior in both strains. We showed that T2DM exerted more pronounced negative effects on the rats with comorbid hypertension as compared to normotensive rats. Overall effects on the studied behavioral parameters are related to decreased exploration of the new environment, increased anxiety-like behavior, and decline in short-term memory. The systemic sub-chronic treatment with an angiotensin AT1 receptor antagonist losartan ameliorated most of these complications.

Entities:  

Keywords:  Anxiety; Diabetes mellitus type 2; Losartan; Memory; Renin Angiotensin Aldosterone System

Mesh:

Substances:

Year:  2020        PMID: 31997264     DOI: 10.1007/s11011-020-00534-1

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  60 in total

1.  Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet-induced obese rats.

Authors:  Helge Müller-Fielitz; Margot Lau; Cathleen Geißler; Lars Werner; Martina Winkler; Walter Raasch
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

2.  Involvement of Spinal Angiotensin II System in Streptozotocin-Induced Diabetic Neuropathic Pain in Mice.

Authors:  Yoshiki Ogata; Wataru Nemoto; Osamu Nakagawasai; Ryota Yamagata; Takeshi Tadano; Koichi Tan-No
Journal:  Mol Pharmacol       Date:  2016-07-11       Impact factor: 4.436

3.  Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats.

Authors:  S Bosnyak; I K Welungoda; A Hallberg; M Alterman; R E Widdop; E S Jones
Journal:  Br J Pharmacol       Date:  2010-01-28       Impact factor: 8.739

4.  Optimization of the mechanical nociceptive threshold testing with the Randall-Selitto assay.

Authors:  Vanessa C Z Anseloni; Matthew Ennis; Michael S Lidow
Journal:  J Neurosci Methods       Date:  2003-12-30       Impact factor: 2.390

5.  Possible synergistic effect of direct angiotensin II type 2 receptor stimulation by compound 21 with memantine on prevention of cognitive decline in type 2 diabetic mice.

Authors:  Jun Iwanami; Masaki Mogi; Kana Tsukuda; Fei Jing; Kousei Ohshima; Xiao-Li Wang; Hirotomo Nakaoka; Harumi Kan-no; Toshiyuki Chisaka; Hui-Yu Bai; Li-Juan Min; Masatsugu Horiuchi
Journal:  Eur J Pharmacol       Date:  2013-12-18       Impact factor: 4.432

6.  Chronic blockade of angiotensin AT₁ receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats.

Authors:  Helge Müller-Fielitz; Nils Hübel; Martin Mildner; Florian M Vogt; Jörg Barkhausen; Walter Raasch
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

7.  Effect of chronic treatment with losartan on streptozotocin induced diabetic rats.

Authors:  B Murali; R K Goyal
Journal:  Indian J Exp Biol       Date:  2002-01       Impact factor: 0.818

8.  Cerebrospinal fluid protein carbonylation identifies oxidative damage in autoimmune demyelination.

Authors:  David N Irani
Journal:  Ann Clin Transl Neurol       Date:  2016-12-20       Impact factor: 4.511

9.  Angiotensin II Causes Apoptosis of Adult Hippocampal Neural Stem Cells and Memory Impairment Through the Action on AMPK-PGC1α Signaling in Heart Failure.

Authors:  Min-Seok Kim; Geun-Hee Lee; Yong-Min Kim; Byoung-Wook Lee; Hae Yun Nam; U-Cheol Sim; Suk-Jung Choo; Seong-Woon Yu; Jae-Joong Kim; Yunhee Kim Kwon; Seong Who Kim
Journal:  Stem Cells Transl Med       Date:  2017-02-28       Impact factor: 6.940

10.  Rat Models of Diet-Induced Obesity and High Fat/Low Dose Streptozotocin Type 2 Diabetes: Effect of Reversal of High Fat Diet Compared to Treatment with Enalapril or Menhaden Oil on Glucose Utilization and Neuropathic Endpoints.

Authors:  Amey Holmes; Lawrence J Coppey; Eric P Davidson; Mark A Yorek
Journal:  J Diabetes Res       Date:  2015-07-02       Impact factor: 4.011

View more
  1 in total

Review 1.  Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective.

Authors:  Alaa Alnefaie; Sarah Albogami
Journal:  Saudi Pharm J       Date:  2020-09-01       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.